Modified saccharides having improved stability in water

Details for Australian Patent Application No. 2003216633 (hide)

Owner Novartis Vaccines and Diagnostics S.r.l.

Inventors Bartoloni, Antonella; Berti, Francesco; Costantino, Paolo; Norelli, Francesco

Agent FB Rice

Pub. Number AU-B-2003216633

PCT Number PCT/IB03/01436

PCT Pub. Number WO2003/080678

Priority 0230163.8 24.12.02 GB; 0220195.2 30.08.02 GB; 0229494.0 18.12.02 GB; 0207117.3 26.03.02 GB

Filing date 26 March 2003

Wipo publication date 8 October 2003

Acceptance publication date 11 February 2010

International Classifications

C07H 13/00 (2006.01) Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids

A61K 39/095 (2006.01) Medicinal preparations containing antigens or antibodies - Neisseria

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07H 13/06 (2006.01) Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids

C07H 13/12 (2006.01) Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids

C07H 15/02 (2006.01) Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals

C07H 15/207 (2006.01) Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals

C08B 37/00 (2006.01) Preparation of polysaccharides not provided for in

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 0230163.8 24.12.02 GB; 0220195.2 30.08.02 GB; 0229494.0 18.12.02 GB; 0207117.3 26.03.02 GB

13 November 2003 Application Open to Public Inspection

  Published as AU-B-2003216633

17 July 2008 Alteration of Name

  The name of the applicant has been altered to Novartis Vaccines and Diagnostics S.r.l.

11 February 2010 Application Accepted

  Published as AU-B-2003216633

10 June 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003216634-Method of inhibiting restenosis

2003216632-METHOD OF SECURING A DEACTIVATION OF A RFID TRANSPONDER